• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.

作者信息

Maral R, Bourut C, Chenu E, Mathe G, Bernon R, Lussan C, Imbach J L, Schein P, Bothorel P

出版信息

Oncology. 1985;42(2):122-8. doi: 10.1159/000226014.

DOI:10.1159/000226014
PMID:3157909
Abstract

L1210 leukemia was used to compare the antitumor activities of three nitrosoureas (chlorozotocin, RFCNU and CNCC) encapsulated in liposomes with those in the free state. The results obtained varied according to the chemical structure of the compound, its solubility in oil or water, the route of administration into the body, and the treatment dose. The application of liposomes in the chemotherapy of malignant disease deserves further investigations.

摘要

相似文献

1
Comparison of the experimental antitumor activities of three nitrosourea derivatives chlorozotocin, RFCNU and CNCC encapsulated in liposomes with those in the free state.
Oncology. 1985;42(2):122-8. doi: 10.1159/000226014.
2
Effects of three new nitrosourea analogs (CNCC, RFCNU and chlorozotocin) on in vivo destruction of L 1210 leukemia cells and on the immune response.
Chemotherapy. 1986;32(2):131-7. doi: 10.1159/000238404.
3
Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in mice.三种新型亚硝基脲类似物：RFCNU、RPCNU和氯脲霉素的比较药理学。I. 对小鼠的抑癌作用
Cancer Chemother Pharmacol. 1979;3(4):217-21. doi: 10.1007/BF00254734.
4
[Effects of derivatives of Ara-C, 5-fluorouracil and nitrosourea against intracerebral implanted L1210 leukemia].
Gan To Kagaku Ryoho. 1987 Feb;14(2):502-5.
5
[Phase II study of 3 new nitrosoureas, 1 American (chlorozotocin) and 2 French (RFCNU and RPCNU)].
Sem Hop. 1982 Sep 16;58(33):1867-71.
6
Relationship of structure to anticancer activity and toxicity of the nitrosoureas in animal systems.动物系统中亚硝基脲类的结构与抗癌活性及毒性的关系。
Cancer Treat Rep. 1986 Jan;70(1):13-30.
7
Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity.
Cancer Res. 1977 Mar;37(3):783-7.
8
Contributions of nitrosoureas to cancer treatment.亚硝基脲类药物在癌症治疗中的作用。
Cancer Treat Rep. 1986 Jan;70(1):31-41.
9
Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent.新型亚硝基脲类抗肿瘤药物氯脲霉素（Nsc - 178248）的药理学
Cancer Treat Rep. 1976 Jun;60(6):801-5.
10
Antitumor effects of GANU and other nitrosourea derivatives against transplantable leukemias and solid tumors in mice.GANU及其他亚硝基脲衍生物对小鼠可移植性白血病和实体瘤的抗肿瘤作用。
Cancer Chemother Pharmacol. 1983;10(3):167-9. doi: 10.1007/BF00255754.

引用本文的文献

1
Liposomes as carriers of cancer chemotherapy. Current status and future prospects.脂质体作为癌症化疗的载体。现状与未来展望。
Drugs. 1993 Oct;46(4):618-38. doi: 10.2165/00003495-199346040-00004.